BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 16932353)

  • 1. Genetic abnormalities of complement regulators in hemolytic uremic syndrome: how do they affect patient management?
    Noris M; Remuzzi G
    Nat Clin Pract Nephrol; 2005 Nov; 1(1):2-3. PubMed ID: 16932353
    [No Abstract]   [Full Text] [Related]  

  • 2. The hemolytic uremic syndromes.
    Caprioli J; Peng L; Remuzzi G
    Curr Opin Crit Care; 2005 Oct; 11(5):487-92. PubMed ID: 16175037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome.
    Le Quintrec M; Zuber J; Moulin B; Kamar N; Jablonski M; Lionet A; Chatelet V; Mousson C; Mourad G; Bridoux F; Cassuto E; Loirat C; Rondeau E; Delahousse M; Frémeaux-Bacchi V
    Am J Transplant; 2013 Mar; 13(3):663-75. PubMed ID: 23356914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement dysregulation in haemolytic uraemic syndrome.
    Bonnardeaux A; Pichette V
    Lancet; 2003 Nov; 362(9395):1514-5. PubMed ID: 14615103
    [No Abstract]   [Full Text] [Related]  

  • 5. Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome.
    Maga TK; Nishimura CJ; Weaver AE; Frees KL; Smith RJ
    Hum Mutat; 2010 Jun; 31(6):E1445-60. PubMed ID: 20513133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful renal transplantation in a patient with atypical hemolytic uremic syndrome carrying mutations in both factor I and MCP.
    Cruzado JM; de Córdoba SR; Melilli E; Bestard O; Rama I; Sánchez-Corral P; López-Trascasa M; Navarro I; Torras J; Gomà M; Grinyó JM
    Am J Transplant; 2009 Jun; 9(6):1477-83. PubMed ID: 19459807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical hemolytic-uremic syndrome.
    Noris M; Remuzzi G
    N Engl J Med; 2009 Oct; 361(17):1676-87. PubMed ID: 19846853
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful simultaneous liver-kidney transplant in an adult with atypical hemolytic uremic syndrome associated with a mutation in complement factor H.
    Wilson C; Torpey N; Jaques B; Strain L; Talbot D; Manas D; Goodship T
    Am J Kidney Dis; 2011 Jul; 58(1):109-12. PubMed ID: 21601332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver-kidney transplantation to cure atypical hemolytic uremic syndrome.
    Saland JM; Ruggenenti P; Remuzzi G;
    J Am Soc Nephrol; 2009 May; 20(5):940-9. PubMed ID: 19092117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on evaluating complement in hemolytic uremic syndrome.
    Kavanagh D; Goodship TH
    Curr Opin Nephrol Hypertens; 2007 Nov; 16(6):565-71. PubMed ID: 18089972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome.
    Caprioli J; Noris M; Brioschi S; Pianetti G; Castelletti F; Bettinaglio P; Mele C; Bresin E; Cassis L; Gamba S; Porrati F; Bucchioni S; Monteferrante G; Fang CJ; Liszewski MK; Kavanagh D; Atkinson JP; Remuzzi G;
    Blood; 2006 Aug; 108(4):1267-79. PubMed ID: 16621965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common genetic variants in complement genes other than CFH, CD46 and the CFHRs are not associated with aHUS.
    Ermini L; Goodship TH; Strain L; Weale ME; Sacks SH; Cordell HJ; Fremeaux-Bacchi V; Sheerin NS
    Mol Immunol; 2012 Jan; 49(4):640-8. PubMed ID: 22153652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent atypical hemolytic uremic syndrome associated with factor I mutation in a living related renal transplant recipient.
    Chan MR; Thomas CP; Torrealba JR; Djamali A; Fernandez LA; Nishimura CJ; Smith RJ; Samaniego MD
    Am J Kidney Dis; 2009 Feb; 53(2):321-6. PubMed ID: 18805611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Atypical hemolytic-uremic syndrome related to abnormalities within the complement system].
    Frémeaux-Bacchi V; Fakhouri F; Roumenina L; Dragon-Durey MA; Loirat C
    Rev Med Interne; 2011 Apr; 32(4):232-40. PubMed ID: 21376430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel use of intravenous immunoglobulin is not restricted to complement hypercatabolism because of factor H deficiency.
    Späth PJ
    Prog Transplant; 2014 Jun; 24(2):120. PubMed ID: 24919726
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of defective complement control in hemolytic uremic syndrome.
    Zipfel PF; Misselwitz J; Licht C; Skerka C
    Semin Thromb Hemost; 2006 Mar; 32(2):146-54. PubMed ID: 16575689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The decay accelerating factor mutation I197V found in hemolytic uraemic syndrome does not impair complement regulation.
    Kavanagh D; Burgess R; Spitzer D; Richards A; Diaz-Torres ML; Goodship JA; Hourcade DE; Atkinson JP; Goodship TH
    Mol Immunol; 2007 May; 44(12):3162-7. PubMed ID: 17368771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful isolated liver transplantation in a child with atypical hemolytic uremic syndrome and a mutation in complement factor H.
    Haller W; Milford DV; Goodship TH; Sharif K; Mirza DF; McKiernan PJ
    Am J Transplant; 2010 Sep; 10(9):2142-7. PubMed ID: 20738267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in CD46, a complement regulatory protein, predispose to atypical HUS.
    Goodship TH; Liszewski MK; Kemp EJ; Richards A; Atkinson JP
    Trends Mol Med; 2004 May; 10(5):226-31. PubMed ID: 15121049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transplantation in atypical hemolytic uremic syndrome.
    Kavanagh D; Richards A; Goodship T; Jalanko H
    Semin Thromb Hemost; 2010 Sep; 36(6):653-9. PubMed ID: 20865642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.